Table S1. Metadata and sample timeline for donors and recipients. Donor and patient demographics are detailed as are the faecal sampling time points (a tick denoting sample collection). In the case of donors, additional samples were collected in order to correlate with recipient timelines. This is an amended table from the study of Jalanka et al. [4] in which the bacteriome in these individuals was examined. (XLSX 11 kb
Number of sequences obtained from each condition and sample. Table S2. Comparison of oral microbial ...
Additional table describing the vOTUs-representative UViGs identified in the participants in the Gut...
Abstract Background Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Cl...
Figure S1. Viral alpha diversity. Alpha diversity estimates per time point for the recipients compar...
The distribution of all 444 donor bins across samples. Yellow markings represent the 92 MAGs. (PNG 7...
Table S1. Primer sequences used in this study. Table S2. Bile acids identified by UPLC-MS analysis. ...
Additional information for samples, metagenomic bins, and metagenome-assembled genomes in our study....
Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium difficile ...
Fecal microbiota ASVs in male skin transplant donors. Table providing percent relative abundance of ...
BackgroundFaecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium ...
BackgroundFaecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium ...
Figure S1. Experimental design. Faecal samples were collected from 14 healthy participants in tripli...
Fecal microbiota ASVs in Jax and Tac mice before and after FMT. Tables providing percent relative ab...
Fecal microbiota ASVs in Jax and Tac mice before and after cohousing. Tables providing percent relat...
Figure S1. PCoA based on Bray-Curtis distances of genus-level relative abundance profiles of the sam...
Number of sequences obtained from each condition and sample. Table S2. Comparison of oral microbial ...
Additional table describing the vOTUs-representative UViGs identified in the participants in the Gut...
Abstract Background Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Cl...
Figure S1. Viral alpha diversity. Alpha diversity estimates per time point for the recipients compar...
The distribution of all 444 donor bins across samples. Yellow markings represent the 92 MAGs. (PNG 7...
Table S1. Primer sequences used in this study. Table S2. Bile acids identified by UPLC-MS analysis. ...
Additional information for samples, metagenomic bins, and metagenome-assembled genomes in our study....
Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium difficile ...
Fecal microbiota ASVs in male skin transplant donors. Table providing percent relative abundance of ...
BackgroundFaecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium ...
BackgroundFaecal microbiota transplantation (FMT) is used in the treatment of recurrent Clostridium ...
Figure S1. Experimental design. Faecal samples were collected from 14 healthy participants in tripli...
Fecal microbiota ASVs in Jax and Tac mice before and after FMT. Tables providing percent relative ab...
Fecal microbiota ASVs in Jax and Tac mice before and after cohousing. Tables providing percent relat...
Figure S1. PCoA based on Bray-Curtis distances of genus-level relative abundance profiles of the sam...
Number of sequences obtained from each condition and sample. Table S2. Comparison of oral microbial ...
Additional table describing the vOTUs-representative UViGs identified in the participants in the Gut...
Abstract Background Faecal microbiota transplantation (FMT) is used in the treatment of recurrent Cl...